Ironwood Pharmaceuticals (IRWD) Current Leases (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Current Leases data on file, last reported at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 2.0% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 2.0% YoY), and the FY2025 full-year result was $3.3 million, up 1.98% from the prior year.
• Current Leases held at $3.3 million in Q1 2026, from $3.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.3 million in Q1 2026 to a low of $3.0 million in Q3 2022.
• A 5-year average of $3.1 million and a median of $3.1 million in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases retreated 3.39% in 2022 and advanced 2.02% in 2024, its largest moves.
• Tracing IRWD's Current Leases over 5 years: stood at $3.1 million in 2022, then rose by 1.99% to $3.1 million in 2023, then advanced by 2.02% to $3.2 million in 2024, then gained by 1.98% to $3.3 million in 2025, then grew by 0.49% to $3.3 million in 2026.
• Business Quant data shows IRWD's Current Leases at $3.3 million in Q1 2026, $3.3 million in Q4 2025, and $3.2 million in Q3 2025.